| Systemic lupus erythematosus |
2.23 |
0.00e+0 |
45/135 (33.33%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Graft-versus-host disease |
2.22 |
0.00e+0 |
32/42 (76.19%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Rheumatoid arthritis |
2.14 |
0.00e+0 |
78/93 (83.87%) |
CXCL12;HLA-DPB1;HLA-DPA1;...
|
| Autoimmune thyroid disease |
2.09 |
0.00e+0 |
46/53 (86.79%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Antigen processing and presentation |
2.07 |
2.33e-3 |
60/78 (76.92%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Allograft rejection |
2.06 |
1.94e-3 |
32/38 (84.21%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Primary immunodeficiency |
1.99 |
1.66e-3 |
33/38 (86.84%) |
LCK;IL2RG;BLNK;...
|
| Th17 cell differentiation |
1.97 |
2.91e-3 |
95/107 (88.79%) |
MAPK13;HLA-DPB1;HLA-DPA1;...
|
| Type I diabetes mellitus |
1.92 |
2.59e-3 |
38/43 (88.37%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Cell cycle |
1.85 |
1.05e-2 |
110/124 (88.71%) |
PLK1;CCNB1;CCNB2;...
|
| Inflammatory bowel disease |
1.85 |
9.52e-3 |
58/65 (89.23%) |
MAF;HLA-DPB1;HLA-DPA1;...
|
| Intestinal immune network for IgA production |
1.84 |
9.70e-3 |
38/48 (79.17%) |
CXCL12;HLA-DPB1;HLA-DPA1;...
|
| Th1 and Th2 cell differentiation |
1.84 |
8.95e-3 |
80/92 (86.96%) |
MAF;MAPK13;HLA-DPB1;...
|
| Propanoate metabolism |
1.79 |
1.25e-2 |
30/34 (88.24%) |
ACAT2;DLD;ABAT;...
|
| Spliceosome |
1.78 |
1.32e-2 |
101/150 (67.33%) |
HSPA8;HSPA2;LSM3;...
|
| Human T-cell leukemia virus 1 infection |
1.77 |
1.60e-2 |
197/219 (89.95%) |
HLA-DPB1;CCNB2;HLA-DPA1;...
|
| Oocyte meiosis |
1.76 |
1.78e-2 |
90/129 (69.77%) |
PLK1;CCNB1;MAPK13;...
|
| Glyoxylate and dicarboxylate metabolism |
1.76 |
1.75e-2 |
23/30 (76.67%) |
ACAT2;DLD;ACO1;...
|
| Asthma |
1.76 |
1.65e-2 |
25/31 (80.65%) |
HLA-DPB1;HLA-DPA1;HLA-DQA1;...
|
| Glycolysis / Gluconeogenesis |
1.73 |
1.92e-2 |
56/67 (83.58%) |
PGAM1;ADH5;DLD;...
|
| Viral protein interaction with cytokine and cytokine re... |
1.72 |
1.83e-2 |
84/100 (84%) |
CXCL12;CXCL5;CXCL1;...
|
| AMPK signaling pathway |
1.70 |
2.22e-2 |
106/120 (88.33%) |
IRS2;CAB39;IGF1;...
|
| T cell receptor signaling pathway |
1.68 |
2.73e-2 |
93/104 (89.42%) |
MAPK13;LCK;MAP2K1;...
|
| Measles |
1.67 |
2.72e-2 |
133/139 (95.68%) |
HSPA8;HSPA2;HSPA6;...
|
| DNA replication |
1.66 |
2.84e-2 |
34/36 (94.44%) |
PCNA;PRIM1;POLA2;...
|
| Valine, leucine and isoleucine degradation |
1.64 |
3.45e-2 |
42/48 (87.5%) |
ACAT2;DLD;ALDH7A1;...
|
| Progesterone-mediated oocyte maturation |
1.61 |
4.35e-2 |
75/100 (75%) |
PLK1;CCNB1;MAPK13;...
|
